James Marken
Chief Operating Officer bij ANI PHARMACEUTICALS, INC.
Vermogen: 8 M $ op 31-03-2024
Profiel
James G.
Marken is currently working as the Senior VP-Operations & Product Development at ANI Pharmaceuticals, Inc. He previously worked as the Vice President-Operations at ANI Pharmaceuticals, Inc. from 2007 to 2013.
Before that, he was a Plant Manager at Solvay Pharmaceuticals, Inc. Mr. Marken completed his undergraduate degree at Bemidji State University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
10-04-2024 | 116 006 ( 0.55% ) | 8 M $ | 31-03-2024 |
Actieve functies van James Marken
Bedrijven | Functie | Begin |
---|---|---|
ANI PHARMACEUTICALS, INC. | Chief Operating Officer | 01-05-2016 |
Eerdere bekende functies van James Marken
Bedrijven | Functie | Einde |
---|---|---|
ANI Pharmaceuticals, Inc. /Old/
ANI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ANI Pharmaceuticals, Inc. leader in the specialty pharmaceuticals industry, ANI Pharmaceuticals develops, manufactures and markets top quality prescription and over-the-counter pharmaceuticals, made in the U.S.A. In three facilities with combined manufacturing, packaging and laboratory capacity exceeding 170,000 sq. ft., ANI develops and manufactures liquid, powder and oral solid dose products, including those requiring containment. ANI also performs contract manufacturing for some of the largest and most respected pharmaceutical companies in the world. The fully-cGMP qualified facilities boast state-of-the-art analytical and stability laboratories for ANI's rapidly expanding research and development program. With several ANDAs pending FDA approval, and in various stages of development, ANI is poised for tremendous growth in the months and years to come! | Chief Operating Officer | 18-07-2013 |
Solvay Pharmaceuticals, Inc.
Solvay Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Solvay Pharmaceuticals, Inc manufactures pharmaceutical products. The company produces therapies for cardi-metabolic, gastroenterological, and neurological disorders. Its brands include Androgel, Klonopin, and ACEON drugs. Solvay Pharmaceuticals was founded by Ernest Solvay in 1863 and is located in Marietta, GA. | Corporate Officer/Principal | - |
Opleiding van James Marken
Bemidji State University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ANI PHARMACEUTICALS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Solvay Pharmaceuticals, Inc.
Solvay Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Solvay Pharmaceuticals, Inc manufactures pharmaceutical products. The company produces therapies for cardi-metabolic, gastroenterological, and neurological disorders. Its brands include Androgel, Klonopin, and ACEON drugs. Solvay Pharmaceuticals was founded by Ernest Solvay in 1863 and is located in Marietta, GA. | Health Technology |
ANI Pharmaceuticals, Inc. /Old/
ANI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ANI Pharmaceuticals, Inc. leader in the specialty pharmaceuticals industry, ANI Pharmaceuticals develops, manufactures and markets top quality prescription and over-the-counter pharmaceuticals, made in the U.S.A. In three facilities with combined manufacturing, packaging and laboratory capacity exceeding 170,000 sq. ft., ANI develops and manufactures liquid, powder and oral solid dose products, including those requiring containment. ANI also performs contract manufacturing for some of the largest and most respected pharmaceutical companies in the world. The fully-cGMP qualified facilities boast state-of-the-art analytical and stability laboratories for ANI's rapidly expanding research and development program. With several ANDAs pending FDA approval, and in various stages of development, ANI is poised for tremendous growth in the months and years to come! | Health Technology |